Urologische Klinik

Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma (2020) Kunz M, Brandl M, Bhattacharya A, Nobereit-Siegel L, Ewe A, Weirauch U, Hering D, et al. Journal article Mitophagy-associated genes PINK1 and PARK2 are independent prognostic markers of survival in papillary renal cell carcinoma and associated with aggressive tumor behavior (2020) Simon AG, Tolkach Y, Esser LK, Ellinger J, Stoehr C, Ritter M, Wach S, et al. Journal article Loss of RBMS1 as a regulatory target of miR-106b influences cell growth, gap closing and colony forming in prostate carcinoma (2020) Dankert JT, Wiesehöfer M, Wach S, Czyrnik ED, Wennemuth G Journal article, Original article CREB1 is affected by the microRNAs miR-22-3p, miR-26a-5p, miR-27a-3p, and miR-221-3p and correlates with adverse clinicopathological features in renal cell carcinoma (2020) Friedrich M, Heimer N, Stoehr C, Steven A, Wach S, Taubert H, Hartmann A, Seliger B Journal article, Original article Assessment of prognosis by established prognosis scores and physicians' judgement in mRCC patients: an analysis of the STAR-TOR registry (2020) Boegemann M, Goebell P, Woike M, Buncke J, Schlack K, Schrader AJ Journal article Immunotherapy for advanced or metastatic urothelial carcinoma (2020) Maisch P, Hwang EC, Narayan V, Bakker CJ, Kunath F, Dahm P Journal article Everolimus after failure of one prior VEGF-targeted therapy in metastatic renal cell carcinoma: Final results of the MARC-2 trial (2020) Staehler M, Stoeckle M, Christoph DC, Stenzl A, Potthoff K, Grimm MO, Klein D, et al. Journal article Piwi-like 1 and piwi-like 2 expression in breast cancer (2020) Erber R, Meyer J, Taubert H, Fasching P, Wach S, Häberle L, Gaß P, et al. Journal article Analysis of CXCL9, PD1 and PD-L1 mRNA in stage T1 non-muscle invasive bladder cancer and their association with prognosis (2020) Kubon J, Sikic D, Eckstein M, Weyerer V, Stöhr R, Neumann A, Keck B, et al. Journal article Characterization of the expression and immunological impact of the transcriptional activator CREB in renal cell carcinoma (2020) Friedrich M, Stoehr C, Jasinski-Bergner S, Hartmann A, Wach S, Wullich B, Steven A, Seliger B Journal article